Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)
Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety as well as cardiovascular effects is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:131 |
|---|---|
| Enthalten in: |
Wiener klinische Wochenschrift - 131(2019), Suppl 1 vom: 13. Mai, Seite 27-38 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2019) |
|---|
| Links: |
|---|
| Themen: |
Blood Glucose |
|---|
| Anmerkungen: |
Date Completed 16.09.2019 Date Revised 25.02.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00508-019-1471-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM296010723 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM296010723 | ||
| 003 | DE-627 | ||
| 005 | 20231225084916.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00508-019-1471-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0986.xml |
| 035 | |a (DE-627)NLM296010723 | ||
| 035 | |a (NLM)30980148 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Clodi, Martin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019) |
| 246 | 3 | 3 | |a Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2019) |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.09.2019 | ||
| 500 | |a Date Revised 25.02.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety as well as cardiovascular effects is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Diabetes mellitus Type 2 | |
| 650 | 4 | |a Glucose lowering | |
| 650 | 4 | |a Therapy | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 650 | 7 | |a Hypoglycemic Agents |2 NLM | |
| 700 | 1 | |a Abrahamian, Heidemarie |e verfasserin |4 aut | |
| 700 | 1 | |a Brath, Helmut |e verfasserin |4 aut | |
| 700 | 1 | |a Brix, Johanna |e verfasserin |4 aut | |
| 700 | 1 | |a Drexel, Heinz |e verfasserin |4 aut | |
| 700 | 1 | |a Fasching, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Föger, Bernhard |e verfasserin |4 aut | |
| 700 | 1 | |a Francesconi, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Fröhlich-Reiterer, Elke |e verfasserin |4 aut | |
| 700 | 1 | |a Harreiter, Jürgen |e verfasserin |4 aut | |
| 700 | 1 | |a Hofer, Sabine E |e verfasserin |4 aut | |
| 700 | 1 | |a Hoppichler, Friedrich |e verfasserin |4 aut | |
| 700 | 1 | |a Huber, Joakim |e verfasserin |4 aut | |
| 700 | 1 | |a Kaser, Susanne |e verfasserin |4 aut | |
| 700 | 1 | |a Kautzky-Willer, Alexandra |e verfasserin |4 aut | |
| 700 | 1 | |a Lechleitner, Monika |e verfasserin |4 aut | |
| 700 | 1 | |a Ludvik, Bernhard |e verfasserin |4 aut | |
| 700 | 1 | |a Luger, Anton |e verfasserin |4 aut | |
| 700 | 1 | |a Mader, Julia K |e verfasserin |4 aut | |
| 700 | 1 | |a Paulweber, Bernhard |e verfasserin |4 aut | |
| 700 | 1 | |a Pieber, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Prager, Rudolf |e verfasserin |4 aut | |
| 700 | 1 | |a Rami-Merhar, Birgit |e verfasserin |4 aut | |
| 700 | 1 | |a Resl, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Riedl, Michaela |e verfasserin |4 aut | |
| 700 | 1 | |a Roden, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Saely, Christoph H |e verfasserin |4 aut | |
| 700 | 1 | |a Schelkshorn, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Schernthaner, Guntram |e verfasserin |4 aut | |
| 700 | 1 | |a Sourij, Harald |e verfasserin |4 aut | |
| 700 | 1 | |a Stechemesser, Lars |e verfasserin |4 aut | |
| 700 | 1 | |a Stingl, Harald |e verfasserin |4 aut | |
| 700 | 1 | |a Toplak, Hermann |e verfasserin |4 aut | |
| 700 | 1 | |a Wascher, Thomas C |e verfasserin |4 aut | |
| 700 | 1 | |a Weitgasser, Raimund |e verfasserin |4 aut | |
| 700 | 1 | |a Winhofer-Stöckl, Yvonne |e verfasserin |4 aut | |
| 700 | 1 | |a Zlamal-Fortunat, Sandra |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Wiener klinische Wochenschrift |d 1946 |g 131(2019), Suppl 1 vom: 13. Mai, Seite 27-38 |w (DE-627)NLM000045071 |x 1613-7671 |7 nnns |
| 773 | 1 | 8 | |g volume:131 |g year:2019 |g number:Suppl 1 |g day:13 |g month:05 |g pages:27-38 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00508-019-1471-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 131 |j 2019 |e Suppl 1 |b 13 |c 05 |h 27-38 | ||